Wanbury Ltd

NSE: WANBURY · BSE: 524212 · Pharmaceuticals & Biotechnology · 31 announcements

Wanbury Ltd news stories on ALFA NewsRead the news →

Share price: ₹198.70
Market cap: ₹694.8 Cr
Revenue (annual): ₹650.3 Cr
Net profit (annual): ₹66.13 Cr
P/E (TTM): 12.4×Sector 47.3×
Promoter holding: 43.02%+0.00% QoQ
FII holding: 0.89%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Business Update 4 Board Meeting Date 4 Management Change 3 Financial Results 3 Annual General Meeting 3 Share Pledge 2 Results Update 2 Product Launch 2 Debt & Borrowing 2 Price Movement Clarification 1 Merger & Restructuring 1 Legal & Regulatory 1 Employee Stock Options 1 Earnings Call 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

26 Jun 2026 18:52 IST NSE

Merger & Restructuring

Wanbury Merger & Restructuring Worth ₹0.04 Cr

Wanbury approved incorporating subsidiary Wanbury Skin Health Limited with an outlay of ₹0.041 Crore. The company also appointed Ernst & Young LLP as internal auditor.

Value: ₹0.04 Cr

Read the filing ↗